Recently, some preclinical and clinical studies have demonstrated the ability of brown
seaweeds in reducing the risk factors for metabolic syndrome. Here, we analyzed the …

Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases.
The increasing NAFLD incidences are associated with unhealthy lifestyles. Currently, there …

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease,
encompassing a range of conditions caused by lipid deposition within liver cells, and is also …

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and
represents a health care burden as treatment options are very scarce. The reason behind …

Nonalcoholic fatty liver disease (NAFLD) ranges in severity from hepatic steatosis to
cirrhosis. Lemon balm and its major constituent, rosmarinic acid (RA), effectively improve the …

In this study, we aimed to determine the relative effectiveness of common dietary
polyphenols or the isoquinoline alkaloid berberine in protecting against molecular …

Marine algae are valuable sources of bioactive compounds that have the potential to be
used in the management of various pathologies. Despite the increasing prevalence of …

Hepatic lipid accumulation and oxidative stress are crucial pathophysiological mechanisms
for non-alcoholic fatty liver disease (NAFLD). Thus, we examined the effect of a combination …

Edible algae Neopyropia yezoensis is used as “Nori”, its dried sheet product, in Japanese
cuisine. Its lipid components reportedly improve hepatic steatosis in obese db/db mice. In …

Non-alcoholic fatty liver disease (NAFLD) and its advanced stage, non-alcoholic
steatohepatitis (NASH), are a major health issue throughout the world. Certain food …